TheStreet Downgrades Apollo Medical (NASDAQ:AMEH) to D

TheStreet downgraded shares of Apollo Medical (NASDAQ:AMEH) from a c- rating to a d rating in a report issued on Thursday morning, TheStreetRatingsTable reports.

A number of other equities analysts have also commented on AMEH. Zacks Investment Research raised Apollo Medical from a strong sell rating to a hold rating in a research note on Tuesday, May 28th. ValuEngine lowered Apollo Medical from a buy rating to a hold rating in a research note on Thursday, June 6th.

Shares of NASDAQ:AMEH opened at $16.11 on Thursday. Apollo Medical has a fifty-two week low of $13.36 and a fifty-two week high of $30.00. The firm has a market capitalization of $576.26 million, a price-to-earnings ratio of 55.55, a P/E/G ratio of 4.42 and a beta of -0.74. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.11.



Apollo Medical (NASDAQ:AMEH) last announced its quarterly earnings results on Monday, March 18th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.20). Apollo Medical had a net margin of 1.79% and a return on equity of 4.87%. The company had revenue of $105.46 million during the quarter. As a group, research analysts predict that Apollo Medical will post 0.34 EPS for the current fiscal year.

In other Apollo Medical news, insider Adrian Vazquez sold 85,000 shares of the business’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $16.35, for a total value of $1,389,750.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Kenneth T. Sim acquired 6,996 shares of Apollo Medical stock in a transaction on Wednesday, June 12th. The stock was acquired at an average cost of $14.50 per share, for a total transaction of $101,442.00. The disclosure for this purchase can be found here. In the last three months, insiders acquired 25,936 shares of company stock worth $373,787. Insiders own 20.50% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Great West Life Assurance Co. Can acquired a new position in Apollo Medical in the fourth quarter worth $99,000. SG Americas Securities LLC acquired a new position in Apollo Medical in the first quarter worth $106,000. ExodusPoint Capital Management LP acquired a new position in Apollo Medical in the first quarter worth $208,000. Strs Ohio boosted its stake in Apollo Medical by 98.6% in the first quarter. Strs Ohio now owns 14,300 shares of the company’s stock worth $261,000 after purchasing an additional 7,100 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Apollo Medical by 154.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 32,242 shares of the company’s stock valued at $640,000 after acquiring an additional 19,561 shares during the period. 6.67% of the stock is currently owned by institutional investors.

About Apollo Medical

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Further Reading: What is Forex?

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.